Product image of Innovace (Enalapril Maleate) supplied by GNH India

Innovace

Active Ingredient:
Enalapril Maleate
Origin:
EU

Innovace (Enalapril Maleate)

Enalapril, the active ingredient in Innovace, is an ACE inhibitor presented as an oral tablet for oral use. It treats hypertension and heart failure in adult patients and is approved for use throughout the European Union.

GNH India supplies Innovace as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Organon Pharma (Uk) Limited

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Enalapril acts on the renin‑angiotensin‑aldosterone system to manage conditions related to elevated blood pressure and cardiac stress.
  • Hypertension: lowers systolic and diastolic pressure, reducing risk of stroke and myocardial infarction.
  • Heart failure: improves symptoms, decreases hospitalisations, and prolongs survival.
  • Post‑myocardial infarction: helps prevent adverse ventricular remodeling and lowers mortality.
  • Diabetic nephropathy: slows progression of renal impairment in patients with type 2 diabetes.

How It Works

  • Enalapril is converted in vivo to enalaprilat, which binds to the active site of angiotensin‑converting enzyme (ACE). This inhibition prevents the conversion of angiotensin I to the potent vasoconstrictor angiotensin II, leading to vasodilation, reduced aldosterone secretion, and decreased sodium and water retention, thereby lowering blood pressure and easing cardiac workload.

Side Effects

Enalapril may cause a range of adverse reactions, from mild to severe.

Common Side Effects

  • Cough: dry, persistent throat irritation.
  • Dizziness or light‑headedness, especially after standing.
  • Headache.
  • Fatigue or general weakness.
  • Nausea or mild gastrointestinal upset.
  • Taste disturbances.

Serious or Rare Side Effects

  • Angioedema: swelling of face, lips, tongue, or airway.
  • Severe hypotension: marked drop in blood pressure.
  • Hyperkalemia: elevated potassium levels.
  • Acute kidney injury: sudden decline in renal function.
  • Hepatic dysfunction: abnormal liver enzymes.
  • Neutropenia or agranulocytosis: reduced white blood cell counts.

Precautions & Warnings

  • Before initiating therapy with Enalapril, clinicians should assess patient history and monitor relevant parameters.
  • Monitor blood pressure: ensure adequate control without excessive hypotension.
  • Assess renal function: check serum creatinine and eGFR periodically.
  • Check electrolytes: especially potassium levels.
  • Avoid use in pregnancy: contraindicated due to fetal toxicity.
  • Use caution in elderly patients: increased sensitivity to hypotensive effects.
  • Store at room temperature: keep in original packaging, protect from moisture and direct sunlight.

Avoid Interactions

Enalapril can interact with several medicines, altering efficacy or safety.

Major Interactions (Avoid)

  • Concomitant use with ARBs or aliskiren in diabetic patients: heightened risk of renal impairment.
  • Potassium‑sparing diuretics or potassium supplements: may cause dangerous hyperkalaemia.
  • Lithium: increased lithium concentrations leading to toxicity.

Moderate Interactions (Monitor Closely)

  • NSAIDs: may blunt antihypertensive effect and affect renal function.
  • Loop or thiazide diuretics: can cause excessive blood pressure reduction.
  • Beta‑blockers: additive hypotensive effect requiring dose adjustments.

Frequently Asked Questions

Innovace contains enalapril, an ACE inhibitor prescribed to manage high blood pressure (hypertension) and to treat heart failure. It may also be used after a heart attack to improve survival and to slow kidney disease progression in patients with diabetes.

Enalapril is converted to enalaprilat, which blocks the angiotensin‑converting enzyme. This prevents formation of angiotensin II, a molecule that narrows blood vessels and stimulates aldosterone release. The result is vasodilation, reduced fluid retention, and lower blood pressure.

The appropriate dose of Innovace is individualized by a qualified prescriber based on the patient’s condition, response, and renal function. Dosage adjustments may be required for elderly patients or those with impaired kidney function.

Enalapril is classified as pregnancy category D, indicating evidence of fetal risk. It should not be used during pregnancy, especially in the second and third trimesters. Limited data are available for breastfeeding; the drug is generally avoided unless the benefit outweighs potential risk.

To place an order, submit an enquiry on the Innovace product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with other antihypertensives, enalapril offers a well‑studied profile for reducing blood pressure and protecting the heart and kidneys. Unlike calcium‑channel blockers, it directly interferes with the renin‑angiotensin system, and unlike diuretics, it does not increase urinary loss of electrolytes, though it may raise potassium levels.

Innovace tablets should be stored at room temperature, below 25 °C, in the original container to protect from moisture and light. Keep the medication out of reach of children and do not use after the expiry date printed on the packaging.

Innovace is taken orally, usually once or twice daily as directed by the prescriber. Tablets should be swallowed whole with a glass of water and can be taken with or without food, unless otherwise advised by the healthcare professional.

The most serious risks include angioedema, which can cause swelling of the face, lips, tongue or airway, and severe hypotension, especially after the first dose. Hyperkalaemia and acute kidney injury are also critical concerns that require regular monitoring.

Innovace is contraindicated in patients with a known hypersensitivity to enalapril or any ACE inhibitor, those with a history of angioedema related to ACE‑inhibitor therapy, and pregnant women. Caution is advised for individuals with severe renal impairment or high potassium levels.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.